25th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170172851 | Device For Detecting The Removal Of Drugs - A device detects the removal of drugs from a drug blister pack. The device has a base for receiving the drug blister pack and a base surface which is configured for contact with the electrically conducting foil that doses the pockets of the blister pack. In the region of the pockets, the base has holes that are configured for the passage of the drugs present in the pockets, every hole being arranged in the region of one of the pockets. A coil is arranged in the region of each of the holes and extends around the respective hole, in particular exclusively the respective hole. A detector unit is provided which produces an electrical field and/or magnetic field in the region of one or more holes by one of the coils and analyzes the voltage or the current on at least one of the coils extending around the hole. | 2017-06-22 |
20170172852 | Child Feeding System - A child feeding system includes a spout pouch having a spout and a pouch formed integrally with the spout and configured to hold a liquid for feeding to a child, and a holder having a top and a body, the top having an opening configured to laterally receive and removably secure the spout to the holder when the spout is pushed transversely into the opening, the opening partially surrounding the spout, and the body having an interior area configured to receive at least a portion of the pouch. Other systems, methods, and components are also provided. | 2017-06-22 |
20170172853 | Baby Food Feeder - A baby food feeder is disclosed. The baby food feeder includes a lid and a food feeding tube. The lid includes a top panel and a tube receiving passageway disposed along and extending through the top panel. The food feeding tube extends through the tube receiving passageway and includes a support connector to the lid. | 2017-06-22 |
20170172854 | BIOACTIVE "SMART" DENTAL COMPOSITE MATERIALS - Provided herein are composite materials comprising a thiol-ene polymer resin in a continuous phase and a filler in a discontinuous phase, the filler comprising fluorapatite crystals and silica. Further provided are methods of using these composite materials as restoratives in dental applications. This dental composite is labeled as “smart” because, when the shrinkage stress of the composite is greater than a programmable or pre-selected threshold level, it will elicit visual clues for the dentist. | 2017-06-22 |
20170172855 | Compositions With Controlled Network Structure - Radically polymerizable dental material, which contains at least one compound of Formula I: | 2017-06-22 |
20170172856 | EFFERVESCENT COMPOSITION - A solid cosmetic product includes an inner non-effervescent material having at least a coloring and a solid carrier material. The solid carrier material is a powder and the non-effervescent material does not effervesce on contact with water. An outer effervescent material is capable of effervescence on contact with water and envelops the inner non-effervescent material. | 2017-06-22 |
20170172857 | FOAMABLE COMPOSITION COMBINING A POLAR SOLVENT AND A HYDROPHOBIC CARRIER - The present invention relates to a foamable vehicle or cosmetic or pharmaceutical composition, comprising: (1) an organic carrier, at a concentration of 10% to 70% by weight, wherein said organic carrier concurrently comprises: (i) at least one hydrophobic organic carrier, and (ii) at least one polar solvent; (2) at least one surface-active agent; (3) water; and (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition. | 2017-06-22 |
20170172858 | OIL-IN-WATER TYPE EMULSIFIED COSMETIC - The present application provides an oil-in-water type emulsified cosmetic which has the effect of beautifying the appearance of skin and also excels in emulsion stability. The oil-in-water type emulsified cosmetic according to the present invention is characterized by comprising (A) 1 to 20 mass % of a hydrophobized titanium oxide having an average particle size of at least 0.1 μm; (B) a sugar ester having a carboxyl group within the structure; (C) a liquid higher fatty acid; (D) a higher alcohol; (E) a non-ionic surfactant; (F) water; and (G) an oil component. | 2017-06-22 |
20170172859 | EMULSIFIERS HAVING WATER-IN-OIL-STABILIZING PROPERTIES AND COMPOSITIONS, USES AND METHODS RELATING TO SAME - Emulsifiers are provided that are able to stabilize water-in-oil emulsions. The emulsifiers are homogenous and have a relatively low melting point (e.g., soft pastes, gels or liquids at room temperature), enabling their use in cold-process methods/formulations which reduce energy consumption, manufacturing costs, as well as allow the use thermolabile active ingredients. The water-in-oil emulsifiers may comprise: (a) polyglycerol fatty acid esters consisting of saturated and unsaturated fatty acid esters of polyglycerol; (b) polyhydroxystearic acid copolymers consisting of copolymers of hydroxystearic acid with saturated and unsaturated fatty acids; and (c) hydroxystearic acid. Methods and uses relating to the emulsifiers are also described, for example in cosmetic and pharmaceutical compositions. | 2017-06-22 |
20170172860 | EMULSION COMPRISING A SILICONE-BASED DENDRITIC FILM-FORMING POLYMER AND A PASTY COMPOUND, TREATMENT PROCESS USING THE SAME AND SUITABLE DEVICE - The present invention relates to a makeup and/or care composition in the form of a liquid water-in-oil emulsion comprising: a. at least one film-forming polymer chosen from vinyl polymers comprising at least one carbosiloxane dendrimer-based unit, b. at least one hydrocarbon-based or silicone-based compound that is pasty at 23° C., c. water, d. at least one non-volatile oil. The present invention also relates to a process for making up and/or caring for the lips, comprising the application to the lips of a composition according to the invention. Finally, the present invention relates to a device comprising the composition according to the invention. | 2017-06-22 |
20170172861 | NOTCH FILTER COATINGS FOR USE IN SUNSCREEN APPLICATIONS - Notch filter coatings for use in sunscreen applications are provided herein. An exemplary composition includes multiple zinc oxide particles suspended within a medium forming sunscreen composition; and a combination of multiple notch filter coating materials individually applied as a distinct layer to each of the multiple zinc oxide particles to create a multi-layered structure surrounding each of the multiple zinc oxide particles within the sunscreen composition, wherein the multi-layered structure: reflects light at a user-determined wavelength range based on the wavelength range at which each of the multiple notch filter coating materials reflects light; and allows wavelengths of light (i) within at least a portion of the ultraviolet spectrum and (ii) outside of the user-determined wavelength range to be absorbed by the multiple zinc oxide particles. | 2017-06-22 |
20170172862 | CONTROLLING ZINC OXIDE PARTICLE SIZE FOR SUNSCREEN APPLICATIONS - Zinc oxide compositions and methods for controlling zinc oxide particle size for sunscreen applications are provided herein. An example composition includes multiple zinc oxide particles, wherein each of the zinc oxide particles is (i) coated with an optical coating material and (ii) of a size that is below a maximum threshold; and a medium layer within which the zinc oxide particles are suspended, wherein the medium layer comprises a mixture of one or more media, and wherein each of the media has a refractive index below a predetermined threshold. | 2017-06-22 |
20170172863 | Apparatus and Method for Preparing Cosmeceutical Ingredients Containing Epi-Dermal Delivery Mechanisms - The skin serves as a barrier that protects the body from the external environment and prevents water loss. This barrier function also prevents most hydrophilic or hydrophobic and large molecular weight ingredients (>500 kDa) from penetrating intact skin. Until recently, methods to increase stratum corneum permeability were generally not effective enough to make the stratum corneum so permeable that the barrier posed by the viable epidermis mattered. However, that has now changed with the development of the present embodiment's physical methods and highly optimized chemical formulations, such that we revisited the permeability of the full epidermis with the example embodiment's constructs and not focus only on the stratum corneum. This example embodiment therefore tests the hypothesis that the viable epidermis offers a significant permeability barrier to both small molecules and macromolecules that becomes the rate limiting step. | 2017-06-22 |
20170172864 | Tooth Whitening Compositions Comprising Peroxide Complex and Percarbonate Salt - Disclosed herein are tooth whitening compositions comprising a peroxide complex comprising hydrogen peroxide and an N-vinyl heterocyclic polymer; sodium percarbonate; and at least one hydrophobic polymer carrier, wherein the hydrogen peroxide of the peroxide complex is present in the tooth whitening composition in an amount ranging from about 3% to about 5% by weight. Further disclosed herein are methods for whitening a surface of a tooth comprising applying a tooth whitening composition as disclosed herein and methods for making a tooth whitening composition. | 2017-06-22 |
20170172865 | IN VIVO ACCELERATED DEGRADATION OF POLYSACCHARIDE-CONTAINING FILLERS - The present invention relates to a composition for the in vivo degradation of polysaccharide-containing fillers by radical degradation. The composition of the invention comprising at least one source of oxygen free radicals and at least one catalyst of oxygen free radical generation from the at least one source of oxygen free radicals. The present invention further relates to methods and uses of said composition for filler correction or reversal. | 2017-06-22 |
20170172866 | Oral Care Whitening Compositions - Described herein are oral care whitening compositions comprising a non-aqueous phase comprising a peroxysulfate whitening agent, a hydrophobic base and at least one hydrophilic polymer, and optionally an aqueous phase comprising at least one hydrophilic polymer. Methods of making and using these compositions are also described herein. | 2017-06-22 |
20170172867 | COMBINATIONS OF PRESERVATIVES FOR HAIR DYES - A cosmetic product for changing the color of keratin fibers, in particular human hair, includes a coloring preparation (F) that is packaged in a reclosable container (C), wherein the coloring preparation (F) includes, in a cosmetic carrier,
| 2017-06-22 |
20170172868 | OCCLUSIVE PERSONAL CARE COMPOSITION - Described herein, are compositions comprising a soluble quaternary ammonium polymer/polyphosphate complex made by combining ingredients comprising a quaternary ammonium polymer and polyphosphates having 2 or more phosphate units. Methods of making and using these compositions are also described. | 2017-06-22 |
20170172869 | Hair Growth Product - A composition and method for treating hair loss is disclosed. The composition comprises water-soluble ionizable metal and non-metal components, aqueous and alcohol-based solvents, potassium iodide and citrus essential oil, and is preferably provided as a non-aerosol spray product that is applied to the hair and scalp. The invention further provides a method of making and using the composition. | 2017-06-22 |
20170172870 | Dentifrice Comprising Zinc - Amino Acid Complex and Phosphates - Disclosed herein are dentifrices comprising a zinc amino acid complex together with soluble phosphate salts. Methods of making and using the dentifrices are also provided. | 2017-06-22 |
20170172871 | PROPELLANT-INCLUDING DEODORANTS AND/OR ANTIPERSPIRANTS COMPRISING AT LEAST TWO DIFFERENT PRESERVATIVES - The present invention relates to propellant-containing deodorant and/or antiperspirant compositions comprising at least two different preservatives. The present invention furthermore relates to a method for preventing and/or reducing perspiration of the body and/or for preventing and/or reducing body odor, using the cosmetic agent according to the invention. | 2017-06-22 |
20170172872 | PROPELLANT-FREE DEODORANTS AND/OR ANTIPERSPIRANTS HAVING SPECIFIC PRESERVATIVE-AGENT COMBINATIONS - The present invention relates to propellant-containing deodorant and/or antiperspirant compositions that include specific preservative-agent combinations. The present invention also relates to a method for preventing and/or reducing the perspiration of the body and/or for preventing and/or reducing body odor by using the cosmetic agents according to the invention and the use of a certain preservative-agent combination to preserve propellant-containing deodorant and/or antiperspirant compositions. | 2017-06-22 |
20170172873 | PROPELLANT-FREE DEODORANTS AND/OR ANTIPERSPIRANTS HAVING SPECIFIC PRESERVATIVE-AGENT COMBINATIONS - The present invention relates to propellant-free deodorant and/or antiperspirant compositions that include specific preservative-agent combinations. The present invention also relates to a method for preventing and/or reducing the perspiration of the body and/or for preventing and/or reducing body odor by using the cosmetic agents according to the invention and the use of a certain preservative-agent combination to preserve propellant-free deodorant and/or antiperspirant compositions. | 2017-06-22 |
20170172874 | METHOD OF USING SONOCHEMICAL ACTIVACTION TO FORM META-STABLE SUBSTANCES - A method for forming a coated particle having a core particle that is fully coated by a dual-layer coating that includes an inner layer formed of a hydrophilic composition and an outer layer formed of a hydrophobic polymer. The core particles are added to a hydrophilic solution and mixed together. The hydrophobic polymer is then added to form a mixture. The mixture is sonicated to coat the particles and the coated particles are separated and dried to form meta-stable coated particles. | 2017-06-22 |
20170172875 | ORAL CARE COMPOSITIONS COMPRISING ZINC AMINO ACID HALIDES - Disclosed herein are oral care compositions comprising a zinc amino acid halide complex, and linear polyvinylpyrrolidone and/or sodium tripolyphosphate, which compositions have improved rheological stability. Methods of making and using the compositions are also provided. | 2017-06-22 |
20170172876 | COMBINATIONS OF PRESERVATIVES FOR HAIR COLORS - An agent for coloring keratinic fibers, particularly human hairs, includes in a cosmetic carrier
| 2017-06-22 |
20170172877 | LEAVE-IN CHEMICAL FOAM COMPRISING BENZOYL PEROXIDE - A composition is described that includes benzoyl peroxide. The composition can be formulated for a leave-in topical application and can be provided in the form of a leave-in foam intended to be applied to the skin. The composition can include:
| 2017-06-22 |
20170172878 | Method of Making a Hair Growth Product - A composition and method for treating hair loss is disclosed. The composition comprises water-soluble ionizable metal and non-metal components, aqueous and alcohol-based solvents, potassium iodide and citrus essential oil, and is preferably provided as a non-aerosol spray product that is applied to the hair and scalp. The invention further provides a method of making and using the composition. | 2017-06-22 |
20170172879 | Method of Using a Hair Growth Product - A composition and method for treating hair loss is disclosed. The composition comprises water-soluble ionizable metal and non-metal components, aqueous and alcohol-based solvents, potassium iodide and citrus essential oil, and is preferably provided as a non-aerosol spray product that is applied to the hair and scalp. The invention further provides a method of making and using the composition. | 2017-06-22 |
20170172880 | Fast Dissolving Peroxymonosulfate Composition - A solid composition for adding to water of an aqueous solution to form a whitening mouthrinse. The solid composition can be in the form of a tablet and contains a salt of peroxymonosulfate as a whitening agent. | 2017-06-22 |
20170172881 | INTERNAL OLEFIN SULFONATE COMPOSITION - Provided are an internal olefin sulfonate composition which is capable of sufficiently enhancing foamability, light foam quality, and instantaneous foam dissipation property, and a cleansing composition containing the internal olefin sulfonate composition. The internal olefin sulfonate composition comprises (A) an internal olefin sulfonate having 12 carbon atoms and (B) an internal olefin sulfonate having 14 carbon atoms, wherein a content mass ratio of the component (A) to the component (B), (A/B), is from 10/90 to 90/10, and a total content of the component (A) and the component (B) in the internal olefin sulfonate is from 60 to 100% by mass. | 2017-06-22 |
20170172882 | FASHIONABLE COPPER SHADES IN A NONIONIC BASE - An agent for oxidatively dyeing keratinous fibers, in particular human hair, includes—in a cosmetic carrier—
| 2017-06-22 |
20170172883 | NAIL COMPOSITIONS CONTAINING INORGANIC GELLING AGENT AND DISPERSION OF ACRYLIC POLYMER PARTICLES - The invention relates to nail compositions comprising at least one dispersion of acrylic polymer particles and at least one inorganic gelling agent. | 2017-06-22 |
20170172884 | PHOTOCURABLE NAIL COMPOSITIONS CONTAINING INORGANIC GELLING AGENT - The invention relates to photocurable compositions comprising at least one inorganic gelling agent. | 2017-06-22 |
20170172885 | PERSONALIZING SUBSTANCE FOR APPLICATION TO THE SKIN OR ADDITION TO TATTOO INK AND METHODS OF PREPARATION THEREOF - Compositions for delivering materials, such as a biological material, sand, soil, metal, water, sea water, holy water, synthetic or biological polymers, cremated ash, ceramics, animal or plant tissue, or another physiologically compatible component having personal significance to an individual are described herein. The material(s) are encapsulated in an inert, non-bioerodible, hydrophobic, polymeric material. Methods of making microparticles encapsulating the personalizing substance and methods of use are also provided. The personalizing substance may be encapsulated in a polymeric non-bioerodible microparticle. The encapsulated personalizing substance may be combined with a carrier for delivery to an individual's skin. In some embodiments, the personalizing substance is added to a tattoo ink and incorporated in a tattoo created on an individual's skin. Following injection in the skin, the encapsulated material remains in the microparticles, and is not released over time. | 2017-06-22 |
20170172886 | Personal Care Compositions - Personal care compositions comprising a dipeptide and methods of using such compositions to treat the condition of keratinous tissue. The C terminal amino acid of said dipeptide is threonine. The personal care composition can be applied topically, ingested orally, injected, or used as part of a combined treatment regimen. | 2017-06-22 |
20170172887 | Methods for Smoothing Wrinkles and Skin Texture Imperfections - A skin smoothing composition that has from about 0.5 to about 10%, by weight, of an interpenetrating polymer that is a co-polymer of polyurethane and a polyacrylic polymer. The composition further contains from about 0.1% to about 5%, by weight, of a thickener made from homopolymers of acrylic acid crosslinked with a cross linker selected from the group consisting of an allyl ether pentaerythritol, allyl ether of sucrose, allyl ether of propylene and mixtures thereof and from about 10 to 98% water. | 2017-06-22 |
20170172888 | Oil-in-Water Emulsion Cosmetic - The present invention has the purpose of providing an oil-in-water emulsion cosmetic that contains a high quantity of an ultraviolet absorbing agent and an ultraviolet scattering agent in the oil phase and achieves a high SPF, while simultaneously having a Distinctive fresh feeling in use when applied to the skin. The present invention provides an oil-in-water emulsion cosmetic characterized by comprising (A) 0.05 to 1% by mass of a hydrophobically modified alkyl cellulose; (B) 5 to 40% by mass of an oil component; (C) 2.5 to 30% by mass of an ultraviolet scattering agent having a hydrophobic surface; and (D) a water phase thickener having low salinity tolerance; wherein the (C) ultraviolet scattering agent is dispersed in the oil phase. | 2017-06-22 |
20170172889 | NAIL COMPOSITIONS CONTAINING ALKYD RESIN - The invention relates to nail compositions comprising at least one alkyd resin. | 2017-06-22 |
20170172890 | PHOTOCURABLE NAIL COMPOSITIONS CONTAINING DISPERSION OF ACRYLIC POLYMER PARTICLES - The invention relates to photocurable compositions comprising at least one dispersion of acrylic polymer particles. | 2017-06-22 |
20170172891 | PRODUCTS AND METHOD FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS - The invention relates to cosmetic products for temporarily shaping keratin fibers, including, relative to the total weight of the product, a) 0.5 to 3.0 wt.-% of at least one hydrophobically modified (meth)acrylic acid copolymer; and b) 0.5 to 5.0 wt.-% of at least one copolymer which is different from copolymer a) and which is obtained by reacting at least one ethylenically unsaturated monomer unit (b1) with at least one saccharide monomer unit (b2), and to the use thereof and to a method for using said products. | 2017-06-22 |
20170172892 | CLEANSING BARS CONTAINING POLYGLYCEROL ESTERS - The present invention provides a cleansing bar having a pH of about 8 or less and that contains a non-soap anionic surfactant, a polyglycerol ester having a peak melting point of about 40° C. or less, a hydrophobic binder, and a water-soluble bar hardener. | 2017-06-22 |
20170172893 | COSMETIC - [Problem] The present invention has an object to provide a cosmetic which is satisfactorily transferred onto a finger or a small tool, is smoothly spread on the skin, forms a non-sticky and uniform cosmetic film, and can achieve a beautiful finish in which the cosmetic effects last for a prolonged time. | 2017-06-22 |
20170172894 | PROPELLANT-FREE DEODORANTS AND/OR ANTIPERSPIRANTS COMPRISING AT LEAST TWO DIFFERENT PRESERVATIVES - The present invention relates to propellant-free deodorant and/or antiperspirant compositions comprising at least two different preservatives. The present invention furthermore relates to a method for preventing and/or reducing perspiration of the body and/or for preventing and/or reducing body odor, using the cosmetic agent according to the invention. | 2017-06-22 |
20170172895 | Topical Anhydrous Fill Formulation For Ultraviolet Filters - An anhydrous base composition including a branched hydrocarbon base oil having 9-16 carbon atoms and a viscosity adjusting agent suitable for use in the formulation of a cosmetic composition and which is compatible with a variety of capsule technologies. Also described is a storage stable anhydrous fill formulation compatible with a variety of different capsule technologies and which includes an anhydrous base composition including a base oil and a viscosity adjusting agent, as well as one or more UV components such as UV filters and, optionally, one or more UV defense boosters. Soft capsule formulations containing UV filters are also disclosed. The soft capsule formulations may include a soft capsule shell and an anhydrous fill material within the shell, which, when dispensed, provides a film including one or more sun protection ingredients. | 2017-06-22 |
20170172896 | OXIDATION COLORING COMPOSITION WITH PROTEIN-SILOXANE POLYMERS - A cosmetic agent for dyeing keratinous fibers, especially human hair, includes at least one specific protein-siloxane polymer and at least one oxidation dye precursor and/or a direct dye, where the use of the at least one protein-siloxane polymer leads to improved care of the keratinous fibers. A corresponding packaging unit (kit of parts) and a method for dyeing keratinous fibers include the cosmetic agent. Lastly, the cosmetic agent is used to care for keratinous fibers with an enhanced care effect. | 2017-06-22 |
20170172897 | DYE COMPOSITION WITH SPECIAL NON-IONIC LINEAR SILICONE POLYMERS - A cosmetic agent for dyeing keratin fibers, in particular human hair, includes at least one special non-ionic linear silicone polymer and at least one oxidation dye pre product and/or a direct dye. The use of the at least one non-ionic linear silicone polymer leads to an improved colorfulness and/or depth of shades. A corresponding packaging unit (kit of parts) and a method for dyeing keratin fibers both include the cosmetic agent. The cosmetic agent and packaging unit including the same are used for increasing the colorfulness and/or depth of shades. | 2017-06-22 |
20170172898 | NAIL COMPOSITIONS CONTAINING SILICONE-ORGANIC POLYMER HYBRID COMPOUND AND ALKYD RESIN - The invention relates to nail compositions comprising at least one silicone-organic polymer hybrid compound and at least one alkyd resin. | 2017-06-22 |
20170172899 | NAIL COMPOSITIONS CONTAINING SILICONE-ORGANIC POLYMER HYBRID COMPOUND - The invention relates to nail compositions comprising at least one silicone-organic polymer hybrid compound. | 2017-06-22 |
20170172900 | OXIDATIVE HAIR LIGHTENERS WITH SPECIAL AMINATED SILICONE POLYMERS - The present invention relates to a cosmetic agent for dyeing, in particular for lightening keratin fibers, in particular human hair, including at least one specific aminated silicone polymer and at least one oxidation dye intermediate and/or one direct dye, wherein the use of the at least one aminated silicone polymer leads to improved care of the keratin fibers with improved hair lightening performance. The invention further relates to a corresponding packaging unit (kit of parts) and to a method for dyeing, in particular lightening, of keratin fibers. Lastly, the invention relates to the use of the cosmetic agent according to the invention and the use of a packaging unit for producing an oxidative hair lightener for care of keratin fibers with improved lightening performance. | 2017-06-22 |
20170172901 | PACKAGING UNIT HAVING PARTICULAR AMINATED SILICONE POLYMER - A packaging unit (kit of parts) for dyeing keratin fibers and related methods. The packaging unit includes, formulated separately from one another, at least one container (C1), comprising a cosmetic agent (M1), which comprises at least one compound, selected from oxidation dye precursors, direct dyes and the mixtures thereof, and at least one aminated silicone polymer, comprising at least one structural unit of formula (I) and at least one structural unit of formula (II) | 2017-06-22 |
20170172902 | AGENT FOR TEMPORARILY RESHAPING KERATIN-CONTAINING FIBERS COMPRISING PRESERVATIVE - A shelf-stable cosmetic agent for temporarily shaping keratin fibers, and in particular human hair, having improved protection against the fading of the color of keratin fibers is provided. | 2017-06-22 |
20170172903 | COMPOSITION WITH OPTICAL EFFECTS - The present invention relates to a cosmetic composition, comprising: (a) at least one oil phase including at least one triglyceride oil; (b) at least one polyol phase including at least one polyol; and (c) at least one surfactant phase including at least one nonionic surfactant, wherein at least one of the phases (a), (b) and (c) is visually distinct from the other(s), and the amount of the triglyceride oil is 7.5% by weight or more, preferably 10.0% by weight or more, and more preferably 15.0% by weight or more, relative to the total weight of the composition. The cosmetic composition according to the present invention can be translucent and exhibit a warm color, in particular a shiny warm color, when mixed well, for example, when shaken by hand, and observed through normal white background light. These unique optical effects can stimulate potential consumers visually. | 2017-06-22 |
20170172904 | ANHYDROUS COMPOSITION INCLUDING A LIPOPHILIC GELLING AGENT, AT LEAST TWO DIFFERENT FILLERS AND AN OIL PHASE - The present invention relates to an anhydrous composition comprising:
| 2017-06-22 |
20170172905 | AGENT FOR TEMPORARILY RESHAPING KERATIN-CONTAINING FIBERS COMPRISING PRESERVATIVE - A shelf-stable cosmetic agent for temporarily shaping keratin fibers, and in particular human hair, has improved protection against phase separation and has increased microbiological stability. | 2017-06-22 |
20170172906 | HAIR GROWTH OIL COMPOSITION - A hair growth oil composition to be applied topically to the human scalp in order to encourage hair growth. The present invention accomplishes these goals through a mixture of ingredients precisely proportioned to achieve a unique chemical composition that brings about maximum results. The ingredients in the composition include coconut oil, emu oil, bhringaraj ( | 2017-06-22 |
20170172907 | AGENT FOR TEMPORARILY RESHAPING KERATIN-CONTAINING FIBERS COMPRISING PRESERVATIVE - A shelf-stable cosmetic agent for temporarily shaping keratin fibers, and in particular human hair, having improved protection against phase separation and having increased microbiological stability is provided. | 2017-06-22 |
20170172908 | AGENT FOR TEMPORARILY RESHAPING KERATIN-CONTAINING FIBERS COMPRISING PRESERVATIVE - Shelf-stable cosmetic agents for temporarily shaping keratin fibers, and in particular human hair, having improved distributability/application are provided. | 2017-06-22 |
20170172909 | Method Of Counteracting The Impact Of Chronic Stress On Skin - The present invention is directed to a method for evaluating cosmetic materials for their efficacy in counteracting the effects of chronic stress on skin using a stress-induced premature senescence phenotype skin model. The present invention is also concerned with compositions containing a combination of actives for blocking or reversing the biological impact of chronic stress on the skin together with actives for rebuilding epidermis so as to restore elasticity. | 2017-06-22 |
20170172910 | COSMETIC COMPOSITION FOR LIGHTENING THE SKIN - A composition including a support including porous polyamide particles, having a specific surface area BET greater than or equal to 8 m | 2017-06-22 |
20170172911 | TOPICAL COSMETIC COMPOSITIONS - Disclosed are compositions and methods for their use for reducing tumor necrosis factor alpha (TNF-α) and/or vascular endothelial growth factor (VEGF) production in skin cells by topically applying to skin in need thereof, a composition comprising an effective amount of | 2017-06-22 |
20170172912 | MAGNOLIA EXTRACT CONTAINING COMPOSITIONS - Disclosed is a method of treating skin, the method comprising topically applying to skin in need of treatment a composition comprising | 2017-06-22 |
20170172913 | Topical Compositions Comprising Pichia Anomala and Chicory Root Extracts - The present invention provides a topical composition comprising an extract of | 2017-06-22 |
20170172914 | INTRAVENOUS ADMINISTRATION OF TRAMADOL - A method of treating pain, e.g., acute post-operative pain, by administering to a human patient(s) a therapeutically effective dose of tramadol intravenously in a dosing regimen which includes one or more loading doses administered at shortened intervals as compared to dosing at steady-state is disclosed. In certain embodiments, the dose of tramadol is from about 45 mg to about 80 mg and the second (and optionally) third doses are intravenously administered at intervals of from about 2 to about 3 hours, and thereafter the tramadol is intravenously administered at a dosing interval of about 4 to about 6 hours, until the patient no longer requires treatment with tramadol. In preferred embodiments, the intravenous dosing regimen provides a Cmax and AUC of tramadol is similar to the Cmax and AUC of an oral dose of 100 mg tramadol HCl given every 6 hours. In certain preferred embodiments, the dosing regimen comprises 50 mg IV tramadol at Hour 0, followed by 50 mg at Hour 2, 50 mg at hour 4, and 50 mg every 4 hours thereafter (e.g., until the patient no longer requires treatment with tramadol). | 2017-06-22 |
20170172915 | COMPOSITIONS AND METHODS FOR TREATING PTERYGIUM - Compositions and methods for inducing pterygium regression from visual axis/central cornea, stabilizing pterygium, treating hyperemia and symptoms in pterygium patients, and treating pterygium recurrence following pterygiectomy are disclosed. The methods include administration of a multikinase inhibitor, an antimetabolite or a combination thereof to patients in need thereof. | 2017-06-22 |
20170172916 | PUNCTAL PLUG WITH ACTIVE AGENT - A method and apparatus for administering an active agent such as a medicine to a subject, uses an ocular implant such as a punctal plug, to which the active agent has been applied. The implant is installed at the eye of the subject for administering the active agent via tissues of the eye. | 2017-06-22 |
20170172917 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME - Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as complex regional pain syndrome. | 2017-06-22 |
20170172918 | SOFT CHEWABLE PHARMACEUTICAL PRODUCTS - A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product. | 2017-06-22 |
20170172919 | Rapidly Dispersible Dosage Form of Oxcarbazepine - A high dose orodispersible dosage form of oxcarbazepine is provided. Drug-containing particles of oxcarbazepine are included within a porous bound matrix. The dosage form disperses in saliva or water in less than 15 sec and it has sufficient hardness to withstand handling and storage. It can be used to treat diseases or disorders that are therapeutically responsive to oxcarbazepine or a derivative thereof. | 2017-06-22 |
20170172920 | LIPOSOMES WITH GINSENOSIDE AS MEMBRANE MATERIAL AND PREPARATIONS AND USE THEREOF - Among others, the present invention provides a blank liposome, preparation methods thereof, and a loaded liposome including the blank liposome and an active substance. The liposomes have a membrane comprising lipids and a ginsenoside of Formula I, and may further comprise a surfactant, a heat-sensitive excipient, a pH sensitive material, or an ion additive. | 2017-06-22 |
20170172921 | POLYPHENOLIC COMPOUNDS ENCAPSUALATED IN LONG CIRCULATING LIPOSOMES AND USE THEREOF - A method for preparing a liposome composition for delivering polyphenolic compounds to the target organs may include preparing a complex that contains at least one polyphenolic compound. Then, encapsulating the polyphenolic compound into a liposome composition by admixing the prepared complex with the liposome ingredients. | 2017-06-22 |
20170172922 | MICRON TAIWANOFUNGUS CAMPHORATUS LIPOSOME STRUCTURE | 2017-06-22 |
20170172923 | COMPOSITION FOR DELIVERING BIOACTIVE MATERIAL OR PROTEIN, AND USE THEREOF - A composition for delivering a bioactive material include a porous silica nanoparticle containing pores with an average pore diameter ranging from 1 nm to 100 nm, at least one of (i) a functional group which binds to the pore surface of the porous silica nanoparticle and gives the pore surface a negative charge or a positive charge, (ii) a ligand which binds to the pore surface of the porous silica nanoparticle and specifically binds to the bioactive material, and (iii) a combination of the functional group and the ligand, and a bioactive material having a size to be accommodated within the pores of the porous silica nanoparticle, the bioactive material bound to said at least one of the functional group and the ligand bound to the pore surface of the mesoporous silica nanoparticle and accommodated within the pores of the porous silica nanoparticle. | 2017-06-22 |
20170172924 | TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM - Provided herein are methods comprising providing a tyrosine derivative and a solid particulate material (and, optionally, melanin) and applying force to said tyrosine derivative and said solid particulate material for a time and under conditions effective to impregnate at least one of said tyrosine derivative and said solid particulate material with the other of said tyrosine derivative and said solid particulate material. The invention also provides compositions comprising at least one of a tyrosine derivative impregnated with a solid particulate material and a solid particulate material impregnated with a tyrosine derivative. | 2017-06-22 |
20170172925 | PROCESS FOR PREPARING A MEDICAMENT - The present invention provides a process for preparing a particulate medicament that has greater homogeneity and a lower adhesion between the particles of the active ingredient and the carrier. The process comprises the steps of: (a) combining a pharmaceutically active ingredient in the form of an agglomerate of primary particles having an agglomerate particle size such that the agglomerate is capable of passing through a sieve having a mesh of 50-3000 .mu·m with a pharmaceutically acceptable particulate carrier, and (b) mixing the resultant material in a mixer to break up the agglomerate into primary particles dispersed in the pharmaceutically acceptable particulate carrier such that 90% or more of the pharmaceutically active ingredient exists as primary particles having a particle size of 50 .mu·m or less. | 2017-06-22 |
20170172926 | SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS AND METHODS OF PREPARATION THEREOF - A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAECD. In particular, the SAE-CD composition possesses an advantageous physicochemical and morphological property profile such that it can be tailored to particular uses. The SAE-CD composition of the invention has improved flow and dissolution performance as compared to known compositions of SAE-CD. | 2017-06-22 |
20170172927 | Nicotine-Containing Solid Oral Formulations and Uses Thereof - Nicotine formulations and their use in therapy, for instance, in nicotine replacement therapy are described. More specifically, the technology relates to solid oral nicotine formulations comprising nicotine, a sugar-alcohol-starch coagglomerate, a sugar alcohol, xylitol, and a coating, which may be used as lozenges for administration through the oral cavity. | 2017-06-22 |
20170172928 | PHARMACEUTICAL SYSTEM FOR ORAL DELIVERY OF SENSITIVE THERAPEUTIC SUBSTANCES - The present invention specifically refers to a pharmaceutical system for preparation of solid pharmaceutical forms for administering therapeutic substances improving their bioavailability; said system is particularly suitable for administering sensitive active principles by their proteinaceous nature or by being nucleic acids since polymeric excipients with good matrix and bioadhesion properties are used which together with the impermeability conferred by the applied coating make the prepared system a delivery form with excellent performance. | 2017-06-22 |
20170172929 | PHARMACEUTICAL COMPOSITION CONTAINING PREGABALIN WITH IMPROVED STABILITY AND METHOD FOR PREPARING SAME - Provided are a sustained-release composition including pregabalin and a pharmaceutically acceptable salt thereof using a gastroretentive drug delivery system (GRDDS), an oral sustained-release formulation using the composition, and a preparation method thereof. In a sustained-release composition according to the present invention and a formulation including the same, a coating compartment including a sugar or a derivative thereof and a plasticizer is introduced onto the outer surface of pregabalin having a less stable structure to ensure stability and to improve compatibility with excipients at the same time, and also to effectively control the release rate. As a result, dosing convenience is improved to provide a gastroretentive drug delivery system having enhanced patient compliance. Therefore, the present invention may exhibit improved therapeutic or prophylactic effects on various neurological diseases, such as neuropathic pain, epilepsy, fibromyalgia syndrome, etc., which have not been easily accomplished due to the characteristics of pregabalin. | 2017-06-22 |
20170172930 | SHELL-AND-CORE DOSAGE FORM APPROACHING ZERO-ORDER DRUG RELEASE - Drugs are formulated as oral dosage forms for controlled release in which the release rate limiting portion is a shell surrounding the drug-containing core. The shell releases drug from the core by permitting diffusion of the drug from the core. The shell also motes gastric retention of the dosage form by swelling upon imbibition of gastric fluid to size that is retained in the stomach during the postprandial or fed mode. | 2017-06-22 |
20170172931 | COMPOSITION FOR PREPARING SOFT CAPSULE SHELL - Provided is a composition for preparing a soft capsule shell that includes a non-animal material, and more particularly a composition for preparing a soft capsule shell, which includes modified starch composed of modified waxy corn starch and modified waxy potato starch, thereby realizing a soft capsule shell having appropriate hardness and elastic strength and delaying a browning phenomenon. The composition includes modified starch composed of modified waxy corn starch and modified waxy potato starch at a weight ratio of 2:8 to 8:2, a modified starch hydrolysate, a gelling agent, a plasticizer and purified water. | 2017-06-22 |
20170172932 | Early Cancer Detection And Enhanced Immunotherapy - A method of therapy for a tumor or other pathology by administering a combination of thermotherapy and immunotherapy optionally combined with gene delivery. The combination therapy beneficially treats the tumor and prevents tumor recurrence, either locally or at a different site, by boosting the patient's immune response both at the time or original therapy and/or for later therapy. With respect to gene delivery, the inventive method may be used in cancer therapy, but is not limited to such use; it will be appreciated that the inventive method may be used for gene delivery in general. The controlled and precise application of thermal energy enhances gene transfer to any cell, whether the cell is a neoplastic cell, a pre-neoplastic cell, or a normal cell. | 2017-06-22 |
20170172933 | LOADABLE POLYMERIC PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME - Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy) phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Further, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging. The particles may include agents for increasing density for achieving useful buoyancy levels in suspension. | 2017-06-22 |
20170172934 | METHOD FOR PRODUCING ENTERIC ALGINATE MICROCAPSULES VIA IONIC GELATION CONTAINING DICLOFENAC OR ONE OF THE SALTS THEREOF AND MULTIPARTICLED PHARMACEUTICAL COMPOSITION CONTAINING THEM - Method for producing enteric microcapsules without coating, containing diclofenac or one of the salts thereof with satisfactory anti-inflammatory activity and low gastric aggressiveness; and a pharmaceutical composition containing them. The method comprises a) preparing a mixture in water-ethanol with an alginate salt, adding diclofenac or one of the salts thereof previously diluted with a surfactant and sodium bicarbonate; b) adding the previous solution to a solution with a calcium salt; c) resuspending the microcapsules obtained and isolated in an aqueous solution of the alginate salt; and d) isolating, drying and sieving through 1000 and 250 micron meshes the microcapsules obtained; and selecting the fraction comprised between both meshes. The pharmaceutical composition can be an oral composition, tablets, chewable tablets, or a powder for suspension in water. | 2017-06-22 |
20170172935 | APPLICATIONS AND TOOLS BASED ON SILICA PARTICLES COATED WITH BIOLOGICAL OR SYNTHETIC MOLECULES - This invention defines gated silica nanoparticles into which chemical cargo materials or substances are embedded and of which surfaces are coated with biologically active gating molecules and apparatus employing such silica nanoparticles. The invention and the apparatus employing the invention have the potential to be used in diverse fields such as health, food and textiles. Furthermore, the applicability of the invention and the apparatus defined in this document is not limited to the above fields and can be extended to many other sectors. | 2017-06-22 |
20170172936 | Drug Delivery Particle and Method for Producing the Same - An object of the present invention is to develop and provide a method for conveniently introducing a nucleic acid, a peptide, and/or a low-molecular-weight compound into an empty capsid with viral early infection activities kept. The present invention provides a method for producing a drug delivery particle, comprising the steps of: mixing an empty capsid or an empty particle with a drug including a nucleic acid, a peptide, and/or a low-molecular-weight compound in a solution comprising 0.1 to 20% of a surfactant; and keeping the obtained mixed solution at −5 to 50° C. to introduce the drug into the empty capsid or the empty particle. | 2017-06-22 |
20170172937 | SYSTEMS AND METHODS FOR PREPARING SOLID LIPID NANOPARTICLES - A continuous process for the manufacture of solid lipid nanoparticles includes preparing a pre-emulsion comprising a lipid and continuously passing the pre-emulsion through a high pressure homogenizer. | 2017-06-22 |
20170172938 | ORAL DELIVERY SYSTEM COMPRISING TWO COMPARTMENTS - An oral delivery system (ODS) is disclosed, the oral delivery system (ODS) comprising a first compartment (FCO) and a second compartment (SCO), said first compartment (FCO) comprising a first component (FC) comprising natural unbranched polysaccharide, said second compartment (SCO) comprising a second component (SC) comprising multivalent cations, wherein the oral delivery system (ODS) is adapted for administering the first and second components (FC, SC) in a synchronized manner to the oral cavity, whereby a bioadhesive gel is formed from said natural unbranched polysaccharide and said multivalent cationsin a cross-linking reaction. | 2017-06-22 |
20170172939 | Use of Cannabinoids in the Treatment of Epilepsy - The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). | 2017-06-22 |
20170172940 | Use of Cannabinoids in the Treatment of Epilepsy - The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). | 2017-06-22 |
20170172941 | Use of Cannabinoids in the Treatment of Epilepsy - The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Aicardi syndrome; CDKL5 and Dup15q in comparison to other seizure types. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). | 2017-06-22 |
20170172942 | ORALLY DISSOLVING FORMULATIONS OF MEMANTINE - Orally dissolving formulations, e.g., tablets (ODTs) and films (ODFs) comprising memantine and methods of treating conditions, including childhood behavioral disorders and Alzheimer's disease, by administering orally dissolving formulations are provided. The orally dissolving formulations of the present invention may be used to treat various conditions, but is particularly suited to treat childhood behavioral disorders, such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) and also to treat elderly patients suffering from Alzheimer's disease. | 2017-06-22 |
20170172943 | TOPICAL COMPOSITIONS AND METHODS FOR MAKING AND USING SAME - The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof. | 2017-06-22 |
20170172944 | METHODS OF TREATING MELANOMA - Methods of regulating disorders and diseases in cells expressing β2-adrenergic receptor (AR), cannabinoid (CB) receptor and epidermal growth factor receptor (EGFR), include treating a disorder or disease, such as a melanoma include administration of a fenoterol analogue. | 2017-06-22 |
20170172945 | METHODS OF TREATING BREAST CANCER - Methods of regulating disorders and diseases in cells expressing β2-adrenergic receptor (AR), cannabinoid (CB) receptor and epidermal growth factor receptor (EGFR), include treating a disorder or disease, such as a breast cancer include administration of a fenoterol analogue. | 2017-06-22 |
20170172946 | MICRO-SOLID PHASE EXTRACTION - A method of producing a biologic liquid sampling tablet is disclosed and includes molecularly imprinting a polymer over a matrix of an analyte of interest for biological testing; and removing the matrix from the imprinted polymer to form a porous tablet. The tablet is sized to be inserted in an ampoule or human oral cavity. | 2017-06-22 |
20170172947 | PHARMACEUTICAL COMPOSITIONS FOR INHALATION - The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles. | 2017-06-22 |
20170172948 | Quick Dissolving Diphenhydramine Oral Dosage Form - An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes. | 2017-06-22 |
20170172949 | COMPOSITION OF 5-NITROBENZOATE DERIVATIVES AS ANTI-METASTATIC AGENT THAT INHIBITS TUMOR CELL-INDUCED PLATELET AGGREGATION - Disclosed are 5-nitrobenzoate derivatives of Formula I, | 2017-06-22 |
20170172950 | New hepatotoxicity-free pharmaceutical composition containing acetaminophen drugs - A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver. The compound is selected from the following group: Tween 20, microcrystalline cellulose, dicalcium phosphate, polyoxyethylene 23 lauryl ether, saccharin, mannitol, polyoxyethylene alkyl ether, sucralose, pyrrolidone, sodium starch glycolate, acrylic resin S100, carboxymethyl cellulose sodium, polyoxyethylene polyoxypropylene, menthol, low-substituted hydrocarbon propyl cellulose, pregelatinized starch, Dextrates NF hydrated, citric acid, polyoxyethylene castor oil, colloidal silica, polyethylene glycol monostearate aliphatic ester, sorbic acid, lemon oil, hydroxypropyl cellulose, sorbitol, acesulfame potassium, hypromellose phthalate, lactose monohydrate, maltodextrin, Brij 58, Brij 76, Tween 80, Tween 40, PEG 400, PEG 4000, PEG 2000, and the like, so as to reduce the side effect of the toxicity caused by acetaminophen to the liver. | 2017-06-22 |